(Image credit: Yulia Burmistrova via Getty Images)
Some reports suggest that people who use weight loss drugs like Ozempic and Wegovy report that they find it much easier to avoid excess alcohol at social events. But does the research support these claims? Do these weight loss products actually help people reduce their alcohol consumption?
While more research is needed, growing evidence suggests that GLP-1 receptor agonists—a class of drugs that includes semaglutide (brand names Ozempic and Wegovy) and liraglutide (Saxenda)—do indeed reduce alcohol consumption, and scientists are hopeful that these drugs could help combat problem drinking.
This research is still in its early stages, and scientists have not yet figured out how these drugs work in the brain to reduce alcohol consumption. However, more than a dozen clinical trials are already underway to answer these questions.
You may like
Sourse: www.livescience.com
